![George Scangos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Scangos
Direktor/Vorstandsmitglied bei
VOYAGER THERAPEUTICS, INC.
Vermögen: 6 Mio $ am 31.05.2026
Profil
George A. Scangos ist ein Geschäftsmann, der bereits 10 verschiedene Unternehmen geleitet hat und derzeit die Position des Präsidenten, Chief Executive Officer & Director bei Vir Biotechnology, Inc. innehat. Er ist außerdem Mitglied des National Board of Visitor an der University of California und im Vorstand von 5 weiteren Unternehmen. In seiner bisherigen Laufbahn hatte George A. Scangos die Position des Director bei Decibel Therapeutics, Inc. inne, Chief Executive Officer & Director bei Biogen, Inc. Chief Executive Officer bei Biogen Idec New Ventures, Inc. und Chief Executive Officer von Biogen Idec, Inc. (North Carolina) (beides Tochtergesellschaften von Biogen, Inc.), President, Chief Executive Officer & Director bei Exelixis, Inc., President für Bayer Biotechnology, Chairman von Anadys Pharmaceuticals, Inc. und Chairman des California Healthcare Institute, Senior Vice President-Research & Development bei Bayer, Inc. und President-Biotechnology Division bei Bayer Corp. sowie Chairman für Pharmaceutical Research & Manufacturers of America und Professor an der Johns Hopkins University. Er erhielt einen Doktortitel von der University of Massachusetts und einen Bachelor-Abschluss von der Cornell University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.03.2026 | 41’750 ( 0.01% ) | 6 Mio $ | 31.05.2026 | |
| 09.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktuelle Nachrichten zu George Scangos
Aktive Positionen von George Scangos
| Unternehmen | Position | Beginn |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 09.05.2023 |
| AGILENT TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 01.01.2011 |
Octave Bioscience, Inc.
 Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | 12.07.2018 |
Biomedical Sciences Careers Program, Inc. | Direktor/Vorstandsmitglied | - |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
UC Davis School of Medicine
 UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
IS Yatirim Menkul Degerler AS (Broker)
 IS Yatirim Menkul Degerler AS (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Life Science Cares, Inc. | Direktor/Vorstandsmitglied | - |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von George Scangos
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von George Scangos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
33
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 33 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Entelos, Inc.
 Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Commercial Services |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Health Technology |
Taconic Biosciences GmbH
 Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Researches genetics and functional genomics | Commercial Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer, Inc.
 Bayer, Inc. Chemicals: AgriculturalProcess Industries Manufactures chemicals, healthcare, agricultural, and life science products | Process Industries |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
California Healthcare Institute
 California Healthcare Institute BiotechnologyHealth Technology Provides biomedical community services | Health Technology |
Museum of Science
 Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
Symphony Evolution, Inc.
 Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical drugs | Health Technology |
IS Yatirim Menkul Degerler AS (Broker)
IS Yatirim Menkul Degerler AS (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biomedical Sciences Careers Program, Inc. | |
Fondation Santé | |
UC Davis School of Medicine
UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baybio Institute | |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Bayer Biotechnology | |
Life Science Cares, Inc. | |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
